SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-021121
Filing Date
2021-04-28
Accepted
2021-04-28 08:15:14
Documents
8
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A sdgr-def14a_20210617.htm DEF 14A 947174
2 GRAPHIC gkh1thxd4nuq000004.jpg GRAPHIC 64981
3 GRAPHIC gkh1thxd4nuq000002.jpg GRAPHIC 1126
4 GRAPHIC gkh1thxd4nuq000003.jpg GRAPHIC 93166
5 GRAPHIC gkh1thxd4nuq000001.jpg GRAPHIC 93166
6 GRAPHIC gkh1thxd4nuq000007.jpg GRAPHIC 56926
7 GRAPHIC gkh1thxd4nuq000005.jpg GRAPHIC 55224
8 GRAPHIC gkh1thxd4nuq000006.jpg GRAPHIC 57885
  Complete submission text file 0001564590-21-021121.txt   1531011
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39206 | Film No.: 21861429
SIC: 2834 Pharmaceutical Preparations